88
4
36
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T4314 | EPZ020411 | EPZ020411 2HCl | Histone Methyltransferase |
EPZ020411 is a specific and effective inhibitor of PRMT6 (IC50=10 nM). | |||
T40350 | HPK1-IN-4 | HPK1-IN-4 | MAPK |
HPK1-IN-4 is an HPK1 (MAPK41) inhibitor with an IC 50 of 0.061 nM. HPK1-IN-4 is often used as a preclinical immunotherapy tool compound. | |||
T63788 | PCLX-001 | Others | |
PCLX-001 is a small-molecule compound that acts as an orally active inhibitor of N-myristoyltransferase (NMT), specifically targeting NMT1 and NMT2 with IC50 values of 5 nM and 8 nM, respectively. This compound demonstra... | |||
T22180 | 3F8 | 3F 8,3F-8 | GSK-3 |
3F8 is a selective GSK-3β inhibitor that can be used as a new tool and potential therapeutic candidate compound for GSK3-related diseases, and can be used in the study of neurological disorders and cancer. | |||
T9314 | CC214-1 | mTOR , Autophagy | |
CC214-1 is an mTOR inhibitor with potential anticancer activity, inhibits protein translation, and induces autophagy. CC214-1 is an in vitro tool compound for exploring the biology of mTOR kinases and can be used to stud... | |||
T64355 | TDI-10229 | cAMP | |
TDI-10229 is a potent and orally available inhibitor of soluble adenylyl cyclase (sAC, ADCY10). TDI-10229 displays nanomolar inhibition of sAC in both biochemical and cellular assays (IC50= 195 nM). TDI-10229 exhibits mo... | |||
T9361 | 5-bromo-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione | 5-bromo-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione | Others |
5-bromo-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione (5-bromo-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione) is a synthetic compound. It has been used as a catalyst and as a tool in enzyme kinetic studies; it has al... | |||
T61868 | Antitumor agent-66 | ||
Antitumor agent-66 (Compound 4) is a derivative of (-)-cleistenolide, showcasing potential as a research tool for cancer diseases [1]. | |||
T38938 | Antibacterial agent 37 | ||
Antibacterial agent 37 is an effective antimicrobial compound. It holds potential as a valuable tool for researching bacterial infections. | |||
T30216 | AV-105 | AV105,AV 105 | |
Av-105 is the precursor of florbetapir (18F). It is a radiopharmaceutical compound scanned by pet, which can be used as a diagnostic tool for Alzheimer's disease. | |||
T61423 | Transthyretin-IN-1 | ||
Transthyretin-IN-1 (Compound 1d) is a potent inhibitor of transthyretin (TTR) fibril formation, making it a valuable tool for investigating Alzheimer’s disease [1]. | |||
T38955 | β-Lactamase-IN-4 | ||
β-Lactamase-IN-4 (WO2013149121A1, compound 708) is a potent β-lactamase inhibitor. It serves as a valuable tool in the investigation of bacterial infections. | |||
T69922 | EPZ020411 HCl | ||
EPZ020411 is a potent and selective PRMT6 inhibitor tool compound. EPZ020411 shows good bioavailability following subcutaneous dosing in rats making it a suitable tool for in vivo studies. EPZ020411 suppresses RCC1 argin... | |||
T39729 | HIV Protease Substrate 1 | ||
HIV Protease Substrate 1 is a fluorogenic compound that offers insights into the enzymatic activity of HIV protease, making it a valuable tool for studying this aspect. | |||
T18373 | N-(Amino-PEG4)-N-Biotin-PEG4-acid | Others | |
N-(Amino-PEG4)-N-Biotin-PEG4-acid is a PEG-based PROTAC linker that incorporates biotin for labeling purposes. This compound serves as a versatile tool in the synthesis of PROTACs[1]. | |||
T39270 | 2-NP-AMOZ | ||
2-NP-AMOZ is a 2-nitrophenyl derivative of AMOZ, which is a metabolite of the antibiotic Furaltadone. This chemical compound specifically serves as a reliable tool for protein bound AMOZ detection. | |||
T61592 | Thalidomide-piperazine hydrochloride | ||
Thalidomide-piperazine hydrochloride is a chemical compound with potential applications in the research of leprosy and multiple myeloma. It serves as a valuable tool in developmental biology, facilitating significant dis... | |||
T61341 | A-908292 | ||
A-908292 is a highly potent and selective inhibitor of acetyl-CoA carboxylase 2 (ACC2), displaying an impressive IC50 of 38 nM. This compound serves as a valuable tool in the investigation of fatty acid metabolism [1]. | |||
T40452 | N-Acetylpsychosine | N-Acetylpsychosine,C2 Galactosylceramide (d18:1/2:0) | |
N-Acetylpsychosine, also known as α-galactosylated C2-ceramide (d18:1/2:0), exhibits immunostimulatory properties. This compound, N-Acetylpsychosine, holds potential as a valuable tool for studying the mechanisms of apop... | |||
T39629 | BRD4 ligand-Linker Conjugate 1 | BRD4 ligand-Linker Conjugate 1 | |
BRD4 Ligand-Linker Conjugate 1 is a compound consisting of a ligand and a linker, specifically designed to bind to the target protein BRD4. This conjugate serves as a valuable tool for synthesizing PROTACs, molecules uti... | |||
T17884 | CIAP1 Ligand-Linker Conjugates 11 Hydrochloride | E3 ligase Ligand-Linker Conjugates 33 Hydrochloride | Others |
cIAP1 Ligand-Linker Conjugates 11 Hydrochloride is a chemical compound consisting of an IAP ligand that targets the E3 ubiquitin ligase, along with a PROTAC linker. It is primarily utilized in the development of SNIPERs,... | |||
T61502 | Antifungal agent 32 | ||
Antifungal agent 32 (compound 1a) is a highly effective antifungal compound. It displays strong inhibitory activity against Candida albicans filamentation and biofilm formation, as well as inhibiting the morphological sw... | |||
T61565 | KDM5B-IN-3 | ||
KDM5B-IN-3 (Compound 5) is an inhibitor of histone lysine-specific demethylase 5B (KDM5B) or JARID1B. It effectively inhibits the activity of KDM5B with an IC50 value of 9.32 μM. Consequently, KDM5B-IN-3 serves as a valu... | |||
T79131 | KAT modulator-1 | Histone Acetyltransferase | |
KAT modulator-1 (Compound 3), an epigenetics research tool, selectively interacts with the full-length p300 protein but not its catalytic domain [1]. | |||
T74339 | DNA crosslinker 3 dihydrochloride | ||
DNA Crosslinker 3 (dihydrochloride) (Compound 1) is a potent minor groove binder, exhibiting a DNA binding affinity (ΔTm) of 1.4°C, and serves as a valuable tool in anticancer research [1]. | |||
T38980 | Mg(II) protoporphyrin IX | ||
Mg(II) protoporphyrin IX is a crucial compound in the synthesis of chlorophyll in Chlorella. It also serves as a negative regulator of nuclear photosynthetic gene expression. Additionally, Mg(II) protoporphyrin IX is emp... | |||
T61073 | KH-259 | ||
KH-259 (compound 1) is a highly potent, selective, and CNS-penetrant HDAC6 inhibitor, demonstrating an IC50 of 0.26 μM. It exerts its antidepressant effects in mice by inhibiting HDAC6 within the brain. Therefore, KH-259... | |||
T18552 | Pomalidomide-amido-C1-Br | Others | |
Pomalidomide-amido-C1-Br is a synthesized conjugate consisting of the Pomalidomide-based cereblon ligand and a linker, functioning as an E3 ligase ligand-linker. This compound serves as a tool for designing a B-Raf PROTA... | |||
T39791 | Mal-amide-PEG2-oxyamine-Boc | Mal-amide-PEG2-oxyamine-Boc | |
Mal-amide-PEG2-oxyamineBoc is a polyethylene glycol (PEG)-based linker molecule that possesses a Boc-protected oxyamine functionality. This compound serves as a valuable tool in the efficient synthesis of PROTACs (proteo... | |||
T74959 | Antifungal agent 41 | ||
Antifungal Agent 41 (compound B01), an effective inhibitor of Candida albicans both in vitro and in vivo, is a potential research tool for invasive fungal infections [1]. | |||
T61796 | MtTMPK-IN-1 | ||
MtTMPK-IN-1 (compound 3) is a highly effective inhibitor of Mycobacterium tuberculosis thymidylate kinase (Mt TMPK), exhibiting an IC50 value of 2.5 μM. It displays moderate to weak activity against Mtb H37Rv while demon... | |||
T39074 | (Rac)-Zevaquenabant | (Rac)-MRI-1867,(Rac)-Zevaquenabant | |
(Rac)-Zevaquenabant ((Rac)-MRI-1867, compound 6b) is a potent and selective antagonist of the cannabinoid receptor type 1 (CB1R) and inducible nitric oxide synthase (iNOS), exhibiting a binding affinity (Ki) of 5.7 nM sp... | |||
T39578 | TPh A | Triphenyl Compound A | |
Triphenyl Compound A (TPh A) is an effective inhibitor of nuclear protein pirin, showing specific binding to pirin with a Ki value of 0.6 uM. Its mechanism of action involves disturbing the formation of the bcl3–pirin co... | |||
T61777 | Anticancer agent 42 | ||
Anticancer agent 42 (compound 10d) is an orally active, potent anticancer agent with demonstrated efficacy against MDA-MB-231 cells, exhibiting an IC50 of 0.07 μM. It exerts its anticancer activity through the activation... | |||
T61785 | BChE-IN-6 | ||
BChE-IN-6 (compound 12) is a highly effective inhibitor of BChE, showcasing a Ki value of 0.182 μM. Notably, BChE-IN-6 exhibits significant chelating abilities towards Zn 2+. Due to these characteristics, BChE-IN-6 serve... | |||
T61543 | CLK1/4-IN-1 | ||
CLK1/4-IN-1 (compound 31) is a highly potent and selective inhibitor of Clk1 and Clk4, with IC50 values of 9.7 nM and 6.6 nM, respectively. It effectively inhibits the growth of T24 cancer cells, with a GI50 value of 1.1... | |||
T61732 | EGFR/HER2-IN-6 | ||
EGFR/HER2-IN-6 (compound 43) is a dual EGFR/HER2 and DHFR inhibitor with potent activity against EGFR kinase, HER2 kinase, and DHFR, characterized by IC50 values of 0.122 μM, 0.078 μM, and 0.585 μM, respectively. This co... | |||
T61579 | BuChE-IN-5 | ||
BuChE-IN-5 (compound 25b) is a highly potent BuChE inhibitor, displaying an IC50 value of 1.94 μM. It effectively inhibits aggregation of Aβ and tau protein in Escherichia coli. Furthermore, BuChE-IN-5 exhibits considera... | |||
T61573 | MtTMPK-IN-5 | ||
MtTMPK-IN-5 (compound 17) is a highly effective inhibitor of M. tuberculosis thymidylate kinase (Mtb TMPK), demonstrating remarkable enzyme inhibitory activity with an IC50 value of 34 μM. Additionally, MtTMPK-IN-5 exhib... | |||
T40131 | SGC-CK2-1 | SGC-CK2-1 | |
SGC-CK2-1 is an ATP-competitive chemical compound that acts as a highly potent and cell-active CK2 inhibitor. It demonstrates excellent selectivity towards both isoforms of human CK2, with IC50 values of 36 nM for CK2α a... | |||
T39772 | BRK inhibitor P21d hydrochloride | BRK inhibitor P21d hydrochloride | |
BRK inhibitor P21d hydrochloride is a highly potent inhibitor of breast tumor kinase (BRK/PTK6), displaying an IC50 of 30 nM. Additionally, it effectively suppresses p-SAM68 with an IC50 value of 52 nM. This compound, BR... | |||
T82801 | C12 NBD Galactosylceramide | ||
C12 NBD Galactosylceramide, a fluorescent dye-labeled variant of galactosylceramide, possesses a C12 nitrobenzoxadiazole (C12 NBD) moiety that enables fluorescence. This compound serves as a tool in imaging research [1]. | |||
T24692 | QAQ dichloride | ||
QAQ dichloride is a photoswitchable compound that blocks voltage-gated Na v and K v channels. Its channel-blocking activity is observed in the trans form of the azobenzene photoswitch, while the cis form does not exhibit... | |||
T14593 | Biotin-PEG3-Mal | Others | |
Biotin-PEG3-Mal is a biotinylated polyethylene glycol (PEG) derivative used as a linker in the synthesis of proteolysis targeting chimeras (PROTACs). By introducing the biotin moiety, it enables specific recognition and ... | |||
T61739 | Dyrk1A-IN-5 | ||
Dyrk1A-IN-5 (compound 5j) is a highly potent and selective inhibitor of DYRK1A, exhibiting an IC50 of 6 nM. It dose-dependently diminishes the phosphorylation of Thr434 in SF3B1, with an IC50 of 0.5 μM. Moreover, Dyrk1A-... | |||
T39109 | ML338 | ML338 | |
ML338 is a selective small molecule inhibitor probe specifically targeting non-replicating Mycobacterium tuberculosis bacilli. It exhibits potent activity against non-replicating M. tuberculosis, with IC90 and IC99 value... | |||
T79315 | PROTAC TG2 degrader-2 | PROTACs | |
PROTAC TG2 degrader-2 (compound 7) is a selective competitive degrader of Transglutaminase 2 (TG2), exhibiting a dissociation constant (Kd) greater than 100 μM. It inhibits cell migration and reduces TG2 levels in ovaria... | |||
T74271 | TRIM24/BRPF1-IN-2 | ||
TRIM24/BRPF1-IN-2 (compound 20l) is an effective dual inhibitor of TRIM24/BRPF1, demonstrating IC50 values of 0.98 μM for TRIM24 and 1.16 μM for BRPF1, respectively. It exhibits strong binding affinity to the bromodomain... | |||
T77967 | MS159 | PROTACs | |
MS159 is a potent PROTAC degrader targeting the nuclear receptor binding SET structural domain protein 2 (NSD2), which inhibits tumor cell growth. This compound serves as a valuable chemical tool for investigating NSD2's... | |||
T81233 | S-(p-Nitrobenzyl)glutathione | ||
S-(p-Nitrobenzyl)glutathione acts as a competitive inhibitor of glutathionase. Rat kidney microsomes convert this compound into associated cysteine derivatives. It serves as a research tool in investigating the catabolis... |
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T39277 | D-Hexamannuronic acid | ||
D-Hexamannuronic acid, an alginate oligomer, is derived from marine brown algae and a restricted group of Gram negative bacteria. This compound serves as a valuable tool for investigating pain and vascular dementia[4]. | |||
T40966 | D-Heptamannuronic acid | ||
D-Heptamannuronic acid, an alginate oligomer, is derived from marine brown algae and a select group of Gram-negative bacteria. This compound serves as a valuable research tool in the study of pain and vascular dementia[4... | |||
T38954 | L-Glyceric acid sodium | ||
L-Glyceric acid sodium is a urinary metabolite predominantly found in individuals with the rare inherited metabolic disorder, L-glyceric aciduria. This compound serves as a diagnostic tool for identifying primary hyperox... | |||
T73068 | Mammea A/BA | ||
Mammea A/BA demonstrates significant efficacy in inhibiting Trypanosoma cruzi (T. cruzi), through mechanisms such as mitochondrial dysfunction, increased production of reactive oxygen species (ROS), and DNA fragmentation... |
カタログ番号 | 製品名 | ||
---|---|---|---|
L2900 | Oxidation-Reduction Compound Library | 1264 compounds | |
1264 small molecule compounds with pro-oxidant or anti-oxidant activity for high-throughput and high-content screening. | |||
L4520 | Anti-Bacterial Compound Library | 904 compounds | |
A unique collection of 904 antibacterial bioactive compounds, a powerful tool for antibacterial drug development; | |||
L3400 | Clinical Compound Library | 3404 compounds | |
A unique collection of 3404 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS); | |||
L4200 | FDA-Approved Drug Library | 1729 compounds | |
A unique collection of 1729 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L1380 | Transcription Factor-Targeted Compound Library | 695 compounds | |
Well-chosen 695 compounds with unique structures targeting transcription factor; | |||
L3100 | Hematopoietic Toxicity Compound Library | 101 compounds | |
A unique collection of 101 compounds with defined hematopoietic toxicity for high throughput and high content drug screening; | |||
L4510 | Anti-Parasitic Compound Library | 419 compounds | |
419 well-chosen unique anti-parasitic small molecules; | |||
L2910 | Antioxidant Compound Library | 1314 compounds | |
Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species (ROS) and a biological system's ability to readily detoxify the reactive intermediates or repair the resulting damage. ... | |||
L8110 | Reprogramming Compound Library | 1813 compounds | |
A unique collection of 1813 reprogramming signaling pathway-related bioactive small molecule compounds for high-throughput, high-content screening. | |||
L6100 | Polyphenolic Natural Product Library | 635 compounds | |
A unique collection of 635 natural polyphenolic compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L1700 | Anti-Viral Compound Library | 1040 compounds | |
A unique collection of 1040 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening; | |||
L9200 | Drug Repurposing Compound Library | 4541 compounds | |
A unique collection of 4541 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L4500 | Anti-Fungal Compound Library | 252 compounds | |
A unique collection of 252 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation. | |||
L2180 | Anti-Cancer Compound Library Plus | 1468 compounds | |
Well-chosen 1468 anti-tumor compounds with unique structures; | |||
L3200 | Autophagy Compound Library | 1248 compounds | |
A unique collection of 1248 compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L9810 | Anti-Fibrosis Compound Library | 1155 compounds | |
A unique collection of 1155 potential anti-fibrosis compounds, can be used in HTS and HCS; | |||
L6710 | Anti-Inflammatory Traditional Chinese Medicine Compound Library | 1246 compounds | |
A collection of 1246 TCM monomers with anti-inflammatory activity or targeting molecular therapeutic targets in inflammation, a powerful tool for drug discovery and mechanism study; | |||
L5510 | Drug-induced Liver Injury (DILI) Compound Library | 1001 compounds | |
A unique collection of 1001 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening; | |||
L6300 | Food as Medicine Compound Library | 1290 compounds | |
A unique collection of 1290 compounds from food as medicine for high throughput and high content screening; | |||
L8200 | Anti-Aging Compound Library | 3279 compounds | |
A unique collection of 3279 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L2195 | Anti-Prostate Cancer Compound Library | 2070 compounds | |
2070 compounds associated with prostate cancer that can be used for high-throughput and high-content screening. | |||
L2193 | Anti-Liver Cancer Compound Library | 1787 compounds | |
1787 species of compounds related to liver cancer that can be used in anti-liver cancer drug development and pharmacological studies. | |||
L6800 | Chinese Pharmacopoeia Natural Product Library | 2051 compounds | |
A unique collection of 2051 natural products included in Chinese Pharmacopoeia (CP), a powerful tool for drug development and pharmacological study; | |||
L2191 | Anti-Breast Cancer Compound Library | 1939 compounds | |
A unique collection of 1939 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study; | |||
L4020 | NO PAINS Compound Library | 9384 compounds | |
L2520 | Glycometabolism Compound Library | 702 compounds | |
702 glycometabolism-related comounds, can be used for HTS and HCT; | |||
L2510 | Lipid Metabolism Compound Library | 492 compounds | |
A unique collection of 492 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS). | |||
L9500 | Target-Focused Phenotypic Screening Library | 1796 compounds | |
A unique collection of 1796 annotated bioactive compounds with clear targets, suitable for phenotypic screening; | |||
L9700 | Endoplasmic Reticulum Stress Compound Library | 193 compounds | |
A unique collection of 193 endoplasmic reticulum stress (ER stress) related compounds used for high throughput screening (HTS) and high content screening (HCS); | |||
L6740 | Anti-Colorectal Cancer Traditional Chinese Medicine Compound Library | 382 compounds | |
A collection of 382 TCM monomers with anti-colorectal activity. An effective tool for drug development and pharmacological studies. | |||
L2194 | Anti-Colorectal Cancer Compound Library | 1545 compounds | |
1545 compounds associated with colorectal cancer that can be used for high-throughput and high-content screening. | |||
L2170 | Immuno-Oncology Compound Library | 449 compounds | |
A unique collection of 449 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening; | |||
L2560 | Metabolism Compound Library | 2320 compounds | |
L6200 | The Yao nationality medicine Library | 221 compounds | |
A collection of 221 natural product molecules originated from Yao medicine, which can be used for high-throughput and high-content screening. | |||
L2550 | Glutamine Metabolism Compound Library | 565 compounds | |
A unique collection of 565 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and ... | |||
L2196 | Anti-Ovarian Cancer Compound Library | 1867 compounds | |